A community for China's biotech and pharmaceutical industries.

The biotech and pharmaceutical industries are taking priority in China. Recent changes to safety regulations and a general reorganization have increased BioChina’s productivity and influence in the life sciences. With a large scientific community, BioChina has appealed to foreign biotech companies, which now have a strong presence within the country and in the global market. China’s strong economy and dedication to the life sciences is expected to contribute to a thriving biotech industry now and in the future.

Sponsor

Hotbed News

GlaxoSmithKline (GSK) Says Lowering Prices in China Caused Higher Sales Wednesday, May 22, 2013 More...

New Tumor-Killer Shows Great Promise in Suppressing Cancers, Nanyang Technological University and Lund University Study Wednesday, May 22, 2013 More...

Concord Medical Services Holdings Limited (CCM) Reports First Quarter 2013 Financial Results Wednesday, May 22, 2013 More...

Mindray Medical Announces Its Recent Filing of Annual Report on Form 20-F With the U.S. Securities and Exchange Commission Tuesday, May 21, 2013 More...

More Details About Hisun-Pfizer Inc. (PFE) and Merck & Co., Inc. (MRK)-Simcere Pharmaceutical Group JVs Tuesday, May 21, 2013 More...

OrbusNeich's Genous™ Stent Associated With Lower Restenosis Rate Compared to Bare Metal Stents in Low-Risk Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Patients Monday, May 20, 2013 More...

Dehaier Medical Systems Ltd. (DHRM) Signs a Strategic Cooperation Agreement With WideMed Monday, May 20, 2013 More...

Week in Review: RuiYi (formerly Anaphore) Signs Up Shanghai's Genor to Develop mAb in China Monday, May 20, 2013 More...

Sinovac Biotech Ltd. (SVA) to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results Friday, May 17, 2013 More...

Amgen (AMGN)'s New JV Fulfills Promise to Emphasize China Thursday, May 16, 2013 More...